Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02424617 |
Title | A Study of BGB324 in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | BerGenBio AS |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | United States | Details | |
Moores UC San Diego Cancer Center | San Diego | California | 92093-0698 | United States | Details | |
Moffit Cancer Centre | Tampa | Florida | 33612 | United States | Details | |
Horizon Oncology,1345 Unity Place | Lafayette | Indiana | 47905 | United States | Details | |
Henry Ford Hospital | Detroit | Michigan | 48202 | United States | Details | |
Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details | |
Mary Crowley Cancer Research Unit | Dallas | Texas | 75230 | United States | Details | |
University of Texas Southwestern Medical Center | Dallas | Texas | 75390-9105 | United States | Details | |
Oncology Consultants | Houston | Texas | 77030 | United States | Details | |
University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |